Changes in the incidence of candidaemia during 2000-2008 in a tertiary medical centre in northern Taiwan

Journal of Hospital Infection

Volumn 78, Issue 1, 2011, Pages 50-53

  Chen, L Y ^a   Liao, S Y ^a   Kuo, S C ^a   Chen, S J ^a   Chen, Y Y ^a,b   Wang, F D ^a,b   Yang, S P ^a,b   Fung, C P ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Candidaemia; Liver cirrhosis; Mortality; Secular trend

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDEMIA; CHILD; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INFANT; KIDNEY DISEASE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; RENAL REPLACEMENT THERAPY; RISK FACTOR; SCHOOL CHILD; TAIWAN; TERTIARY HEALTH CARE; URINARY CATHETER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDEMIA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DIALYSIS; FEMALE; HOSPITALS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; TAIWAN; YOUNG ADULT;

EID: 79954609854     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.12.007     Document Type: Article

References (30)

1. Pappas P.G., Kauffman C.A., Andes D., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503-535.
2. Chen Y.C., Chang S.C., Sun C.C., Yang L.S., Hsieh W.C., Luh K.T. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 1997, 18:369-375.
3. Gudlaugsson O., Gillespie S., Lee K., et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003, 37:1172-1177.
4. Tsai C.C., Wang C.C., Kuo H.Y., et al. Adult candidemia at a medical center in northern Taiwan: a retrospective study. J Microbiol Immunol Infect 2008, 41:414-421.
5. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317.
6. Bassetti M., Righi E., Costa A., et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006, 6:21.
7. Davis S.L., Vazquez J.A., McKinnon P.S. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother 2007, 41:568-573.
8. Pfaller M.A., Diekema D.J., Jones R.N., et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001, 39:3254-3259.
9. Horn D.L., Neofytos D., Anaissie E.J., et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009, 48:1695-1703.
10. Pappas P.G., Rex J.H., Lee J., et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003, 37:634-643.
11. Tortorano A.M., Peman J., Bernhardt H., et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004, 23:317-322.
12. Trick W.E., Fridkin S.K., Edwards J.R., Hajjeh R.A., Gaynes R.P. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002, 35:627-630.
13. Hobson R.P. The global epidemiology of invasive Candida infections - is the tide turning?. J Hosp Infect 2003, 55:159-168. quiz 233.
14. Hsueh P.R., Teng L.J., Yang P.C., Ho S.W., Luh K.T. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole. Microb Drug Resist 2002, 8:311-319.
15. Garbino J., Kolarova L., Rohner P., Lew D., Pichna P., Pittet D. Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital. Medicine (Baltimore) 2002, 81:425-433.
16. Goodman J.L., Winston D.J., Greenfield R.A., et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992, 326:845-851.
17. Lam S.W., Eschenauer G.A., Carver P.L. Evolving role of early antifungals in the adult intensive care unit. Crit Care Med 2009, 37:1580-1593.
18. Rieger C.T., Ostermann H. Empiric vs. preemptive antifungal treatment: an appraisal of treatment strategies in haematological patients. Mycoses 2008, 51(Suppl. 1):31-34.
19. Rotstein C., Bow E.J., Laverdiere M., Ioannou S., Carr D., Moghaddam N. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect Dis 1999, 28:331-340.
20. Winston D.J., Pakrasi A., Busuttil R.W. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 131:729-737.
21. Horvath L.L., George B.J., Murray C.K., Harrison L.S., Hospenthal D.R. Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for candida growth detection. J Clin Microbiol 2004, 42:115-118.
22. Jamal W., Tamaray G., Pazhoor A., Rotimi V.O. Comparative evaluation of BacT/ALERT 3D and BACTEC systems for the recovery of pathogens causing bloodstream infections. Med Princ Pract 2006, 15:223-227.
23. Krcmery V., Barnes A.J. Non-albicans Candida spp causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002, 50:243-260.
24. Wingard J.R. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995, 20:115-125.
25. Blot S., Vandewoude K., Hoste E., Poelaert J., Colardyn F. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata. J Hosp Infect 2001, 47:308-313.
26. Safdar A., Bannister T.W., Safdar Z. The predictors of outcome in immunocompetent patients with hematogenous candidiasis. Int J Infect Dis 2004, 8:180-186.
27. Cheng Y.R., Lin L.C., Young T.G., Liu C.E., Chen C.H., Tsay R.W. Risk factors for candidemia-related mortality at a medical center in central Taiwan. J Microbiol Immunol Infect 2006, 39:155-161.
28. Dimopoulos G., Piagnerelli M., Berre J., Eddafali B., Salmon I., Vincent J.L. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003, 15:71-75.
29. Meersseman W., Vandecasteele S.J., Wilmer A., Verbeken E., Peetermans W.E., Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004, 170:621-625.
30. Cheruvattath R., Balan V. Infections in patients with end-stage liver disease. J Clin Gastroenterol 2007, 41:403-411.